Liquidia Stock Craters After Losing Patent Case to United Therapeutics
A federal court ruled against Liquidia on two patent claims, handing a win to rival United Therapeutics and threatening the drugmaker's product pipeline.
Liquidia shares fell sharply on September 30 after a court sided with United Therapeutics on two patent infringement claims.
BREAKING STORYBEARISH